NCT00082069View on ClinicalTrials.gov

Invaplex 50 Vaccine Dose-Ranging

PHASE1CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

April 30, 2004

Primary Completion Date

November 30, 2006

Study Completion Date

November 30, 2006

Conditions
Diarrhea
Interventions
BIOLOGICAL

Shigella flexneri 2a Invaplex 50

Trial Locations (1)

20910

Walter Reed Army Institute of Research, Silver Spring

All Listed Sponsors
lead

U.S. Army Medical Research and Development Command

FED

NCT00082069 - Invaplex 50 Vaccine Dose-Ranging | Biotech Hunter | Biotech Hunter